PUBLISHER: Allied Market Research | PRODUCT CODE: 1239536
PUBLISHER: Allied Market Research | PRODUCT CODE: 1239536
The global moist wound dressings market size is estimated to garner $6,807.2 million by 2031, expanding from $4,120 million in 2021 at a CAGR of 5.2% from 2022 to 2031.
The demand for moist wound dressings is predominantly associated with the increase in incidence of chronic wounds associated with various chronic disorders such as cancer and diabetes. The rise in incidences of active wounds such as burns, surgical wounds, and others has increased the demand for moist wound dressings market. Growth in demand for low-cost treatment of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and others has boosted the moist wound dressings market size in the recent years. Furthermore, the increase in demand for faster healing cost-effectiveness offered by moist wound dressings is projected to drive the moist wound dressings market trend.
However, moist wound dressing is not appropriate for all types of infections such as necrotic infections caused by neuropathy and ischemia. These types of injuries should be kept dry or continuously monitored. This is estimated to restrain the moist wound dressings market growth in the coming years.
Moist wound dressings have an optimally moist environment that leads to a faster healing process, which is three to five times faster than the dry healing process. With moist wound dressing, keratinocyte cells that form a major part of the epidermis can easily travel to the wound surface for a faster healing process. The moist environment creates a hypoxic environment, which reduces the incidence of wound infection by reducing the pH and making the wound area inhospitable to bacteria. These factors are anticipated to generate excellent opportunities in the moist wound dressings market during the forecast period.
The COVID-19 pandemic had a negative influence on the moist wound dressings market. This is because only the cases of severe infections and injuries were admitted to hospitals for treatment. Due to the fear of spread of coronavirus among people, social distancing norms led to fewer hospital admissions. Telemedicine helped to reduce the danger of infection and contact between physicians and patients during the pandemic.
The key players profiled in this report include: Coloplast A/S, 3M, Cardinal Health, Inc., Medline Industries, Inc., Smith & Nephew plc, B. Braun, Convatec Group plc, Systagenix Wound Management Ltd., Derma Sciences, and Hollister Incorporated.